117 related articles for article (PubMed ID: 18404787)
1. Impact of body mass index on cancer development.
Yumuk PF; Dane F; Yumuk VD; Yazici D; Ege B; Bekiroglu N; Toprak A; Iyikesici S; Basaran G; Turhal NS
J BUON; 2008; 13(1):55-9. PubMed ID: 18404787
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers associated with breast cancer are associated with obesity.
Sauter ER; Scott S; Hewett J; Kliethermes B; Ruhlen RL; Basarakodu K; de la Torre R
Cancer Detect Prev; 2008; 32(2):149-55. PubMed ID: 18639389
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy weight gain and premenopausal breast cancer risk.
Hilakivi-Clarke L; Luoto R; Huttunen T; Koskenvuo M
J Reprod Med; 2005 Nov; 50(11):811-6. PubMed ID: 16419626
[TBL] [Abstract][Full Text] [Related]
4. Body mass index and mortality among older breast cancer survivors in the Study of Osteoporotic Fractures.
Reeves KW; Faulkner K; Modugno F; Hillier TA; Bauer DC; Ensrud KE; Cauley JA;
Cancer Epidemiol Biomarkers Prev; 2007 Jul; 16(7):1468-73. PubMed ID: 17627012
[TBL] [Abstract][Full Text] [Related]
5. Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States).
Li CI; Malone KE; Daling JR
Cancer Causes Control; 2006 Jun; 17(5):695-703. PubMed ID: 16633917
[TBL] [Abstract][Full Text] [Related]
6. Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea.
Chung YW; Han DS; Park YK; Son BK; Paik CH; Lee HL; Jeon YC; Sohn JH
Dig Liver Dis; 2006 Sep; 38(9):668-72. PubMed ID: 16790371
[TBL] [Abstract][Full Text] [Related]
7. Leptin expression in breast nipple aspirate fluid (NAF) and serum is influenced by body mass index (BMI) but not by the presence of breast cancer.
Sauter ER; Garofalo C; Hewett J; Hewett JE; Morelli C; Surmacz E
Horm Metab Res; 2004 May; 36(5):336-40. PubMed ID: 15156414
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk and the combined effect of environmental estrogens.
Ibarluzea Jm Jm; Fernández MF; Santa-Marina L; Olea-Serrano MF; Rivas AM; Aurrekoetxea JJ; Expósito J; Lorenzo M; Torné P; Villalobos M; Pedraza V; Sasco AJ; Olea N
Cancer Causes Control; 2004 Aug; 15(6):591-600. PubMed ID: 15280638
[TBL] [Abstract][Full Text] [Related]
9. Body weight and body mass index and ovarian cancer risk: a case-control study in China.
Zhang M; Xie X; Holman CD
Gynecol Oncol; 2005 Aug; 98(2):228-34. PubMed ID: 15979697
[TBL] [Abstract][Full Text] [Related]
10. Obesity and risk of cancer in postmenopausal Korean women.
Song YM; Sung J; Ha M
J Clin Oncol; 2008 Jul; 26(20):3395-402. PubMed ID: 18612154
[TBL] [Abstract][Full Text] [Related]
11. Anthropometric measures, plasma adiponectin, and breast cancer risk.
Tian YF; Chu CH; Wu MH; Chang CL; Yang T; Chou YC; Hsu GC; Yu CP; Yu JC; Sun CA
Endocr Relat Cancer; 2007 Sep; 14(3):669-77. PubMed ID: 17914097
[TBL] [Abstract][Full Text] [Related]
12. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
Wolf LA; Terry PD; Potter JD; Bostick RM
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
[TBL] [Abstract][Full Text] [Related]
13. Body size as a factor in different ages and breast cancer risk in Taiwan.
Chie WC; Li CY; Huang CS; Chang KJ; Lin RS
Anticancer Res; 1998; 18(1B):565-70. PubMed ID: 9568178
[TBL] [Abstract][Full Text] [Related]
14. Adenocarcinoma of the oesophagus and gastric cardia: male preponderance in association with obesity.
Ryan AM; Rowley SP; Fitzgerald AP; Ravi N; Reynolds JV
Eur J Cancer; 2006 May; 42(8):1151-8. PubMed ID: 16630714
[TBL] [Abstract][Full Text] [Related]
15. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
[TBL] [Abstract][Full Text] [Related]
16. Comparison between hospitalized and screening controls in studies assessing breast cancer risk.
Garbers S; Dubin N; Toniolo P; Wynder EL; Taioli E
Bull Cancer; 2004 Jun; 91(6):E211-24. PubMed ID: 15562565
[TBL] [Abstract][Full Text] [Related]
17. Carboplatin dosing in obese women with ovarian cancer: a Gynecologic Oncology Group study.
Wright JD; Tian C; Mutch DG; Herzog TJ; Nagao S; Fujiwara K; Powell MA
Gynecol Oncol; 2008 Jun; 109(3):353-8. PubMed ID: 18407341
[TBL] [Abstract][Full Text] [Related]
18. Body mass index in the evaluation of thyroid cancer risk.
Mijović T; How J; Pakdaman M; Rochon L; Gologan O; Hier MP; Black MJ; Young J; Tamilia M; Payne RJ
Thyroid; 2009 May; 19(5):467-72. PubMed ID: 19415996
[TBL] [Abstract][Full Text] [Related]
19. Predictors of lymphedema in patients with breast cancer undergoing axillary lymph node dissection in Hong Kong.
Mak SS; Yeo W; Lee YM; Mo KF; Tse KY; Tse SM; Ho FP; Kwan WH
Nurs Res; 2008; 57(6):416-25. PubMed ID: 19018216
[TBL] [Abstract][Full Text] [Related]
20. Relation of body mass index (BMI) to disease free (DFS) and distant disease free survivals (DDFS) among Turkish women with operable breast carcinoma.
Demirkan B; Alacacioglu A; Yilmaz U
Jpn J Clin Oncol; 2007 Apr; 37(4):256-65. PubMed ID: 17553816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
